Cardiovascular

Euradal 5MG Y 10MG (bisoprolol)

Beta-blocking agents, selective.

RRP* (5 mg – 30 tablets): 2,36€

RRP* (5 mg – 60 tablets): 3,28€

RRP* (10 mg – 30 tablets): 3,28€

RRP* (10 mg – 60 tablets): 6,56€

(Product financed by the National Health System)

DATA SHEET

Lacerol HTA Retard 240mg (diltiazem)

Selective calcium-channel blockers with direct cardiac effects. Benzothiazepine derivatives.

RRP* (20 capsules): 12,18€

RRP* (30 capsules): 18,26€

(Product financed by the National Health System)

DATA SHEET

Lidaltrin 5MG, 20MG, 40MG (quinapril)

Agents acting on the renin-angiotensin system. ACE inhibitors, plain.

RRP* (5 mg – 60 tablets): 2,50€

RRP* (20 mg – 28 tablets): 4,65€

RRP* (40 mg – 28 tablets): 9,30€

(Product financed by the National Health System)

DATA SHEET

Lidaltrin-Diu (quinapril + HydrochlorotHiazidE)

ACE inhibitors, combinations. ACE inhibitors and diuretics.

RRP* (28 tablets): 3,04€

(Product financed by the National Health System)

DATA SHEET

Lacerol Retard 60mg (diltiazem)

Selective calcium-channel blockers with direct cardiac effects. Benzothiazepine derivatives.

RRP* (30 tablets): 4,57€

RRP* (60 tablets): 9,13€

(Product financed by the National Health System)

DATA SHEET

Lacerol Retard 90mg (diltiazem)

Selective calcium-channel blockers with direct cardiac effects. Benzothiazepine derivatives.

RRP*: 13,71€

(Product financed by the National Health System)

DATA SHEET

Lacerol Retard 120mg (diltiazem)

Selective calcium-channel blockers with direct cardiac effects. Benzothiazepine derivatives.

RRP*: 18,26€

(Product financed by the National Health System)

DATA SHEET

Lacerol Retard 180mg (diltiazem)

Selective calcium-channel blockers with direct cardiac effects. Benzothiazepine derivatives.

RRP*: 27,40€

(Product financed by the National Health System)

DATA SHEET

Lacerol Cor Retard 240mg (diltiazem)

Selective calcium-channel blockers with direct cardiac effects. Benzothiazepine derivatives.

RRP* (30 tablets): 18,26€

(Product financed by the National Health System)

DATA SHEET

Uniket 20MG, 40MG Y (ISOSORBIDE MONONITRATE)

Vasodilators used in cardiac diseases. Organic nitrates.

RRP* (20 mg – 40 tablets): 2,50€

RRP* (20 mg – 80 tablets): 4,43€

RRP* (40 mg – 20 tablets): 2,50€

RRP* (40 mg – 40 tablets): 4,43€

(Product financed by the National Health System)

DATA SHEET

Uniket Retard 50MG (ISOSORBIDE mononitratE)

Vasodilators used in cardiac diseases. Organic nitrates.

RRP* (30 tablets): 4,15€

(Product financed by the National Health System)

DATA SHEET

NITROPLAST 5MG, 10MG, 15MG (NITROGLYCERIN)

Vasodilators used in cardiac diseases. Organic nitrates.

RRP* (5 mg – 30 patches): 7,71€

RRP* (10 mg – 30 patches): 15,42€

RRP* (15 mg – 60 patches): 23,14€

(Product financed by the National Health System)

DATA SHEET

Iso-Lacer (ISOSORBIDE DINITRATE)

Vasodilators used in cardiac diseases. Organic nitrates.

RRP* (30 tablets): 1,51€

(Product financed by the National Health System)

DATA SHEET

Euradal 5MG Y 10MG

(bisoprolol)

Beta-blocking agents, selective.

RRP* (5 mg – 30 tablets): 2,36€

RRP* (5 mg – 60 tablets): 3,28€

RRP* (10 mg – 30 tablets): 3,28€

RRP* (10 mg – 60 tablets): 6,56€

(Product financed by the National Health System)

DATA SHEET

Secalip 145MG, 200MG,

250MG Y SECALIP SUPRA 160MG (fenofibratE)

Lipid-modifying agents, plain. Fibrates.

RRP* (145 mg – 30 tablets): 4,43€

RRP* (200 mg – 60 capsules): 5,46€

RRP* (250 mg – 30 capsules): 6,82€

RRP* (SUPRA 160 mg – 30 tablets): 4,89€

(Product financed by the National Health System)

DATA SHEET

Pantok 10MG Y 20MG (simvastatin)

Lipid-modifying agents, plain. HMG CoA reductase inhibitors.

RRP* (10 mg – 28 tablets): 0,95€

RRP* (20 mg – 28 tablets): 1,58€

(Product financed by the National Health System)

DATA SHEET

Pantok Forte 40mg (simvastatin)

Lipid-modifying agents, plain. HMG CoA reductase inhibitors.

RRP* (20 tablets): 2,17€

(Product financed by the National Health System)

DATA SHEET

Pravafenix 40/160mg (PRAVASTATIN SODIUM + FENOFIBRATE)

Lipid-modifying agents, Combinations. HMG CoA reductase inhibitors in combination with other lipid-modifying agents.

RRP* (30 tablets): 12,97€

(Product financed by the National Health System)

DATA SHEET

Roname 2MG Y 4MG (glimepiridE)

Oral blood-glucose-lowering drugs. Sulfonamides, urea derivatives.

RRP* (2 mg – 30 tablets): 2,54€

RRP* (2 mg – 120 tablets): 10,18€

RRP* (4 mg – 30 tablets): 5,09€

RRP* (4 mg – 120 tablets): 20,36€

(Product financed by the National Health System)

DATA SHEET

EKISTOL 50MG (CILOSTAZOL)

Symptomatic treatment of intermittent claudication.

RRP* (56 tablets): 10,49€

(Product financed by the National Health System)

DATA SHEET

EKISTOL 100MG (CILOSTAZOL)

Symptomatic treatment of intermittent claudication.

RRP* (56 tablets): 20,98€

(Product financed by the National Health System)

DATA SHEET